Health & bio
Eli Lilly Foundayo Launches Three Months Behind Novo Nordisk
Eli Lilly's Foundayo entered the market three months after its competitor but is projected to capture 60% of the daily oral market by 2030.
Primary sources · 1
Eli Lilly's Foundayo entered the market three months after its competitor but is projected to capture 60% of the daily oral market by 2030.
7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.